Citation Impact

Citing Papers

Optical coherence tomography angiography
2017 Standout
Optical Coherence Tomography–Defined Changes Preceding the Development of Drusen-Associated Atrophy in Age-Related Macular Degeneration
2014
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
2016
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
2016
Screening Examination of Premature Infants for Retinopathy of Prematurity
2018 Standout
Age-related macular degeneration
2018 Standout
Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
2017 Standout
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
2013
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
2014
Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity
2016

Works of Sofia Fonseca being referenced

Vascular endothelial growth factor plasma levels before and after treatment of neovascular age‐related macular degeneration with bevacizumab or ranibizumab
2011
Arterial Thromboembolic Events in Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Bevacizumab or Ranibizumab
2011
Topography of Geographic Atrophy in Age-Related Macular Degeneration
2012
Rankless by CCL
2026